Research on the Treatment of Severe Community-acquired Pneumonia in Children
Severe Pneumonia
About this trial
This is an interventional treatment trial for Severe Pneumonia focused on measuring Severe pneumonia, children, glucocorticoid, Randomized Controlled Trial
Eligibility Criteria
Inclusion Criteria: 1 month-< 18 years old. Clinical diagnosis of community-acquired pneumonia (fever, cough, sputum, chest pain, dyspnea, abnormal breath sounds in the lungs, imaging pneumonia changes). Meet any of the following: (1) the general condition is very poor; (2) refusal to eat or dehydration; (3) Significantly increased respiratory rate (70 times/min > infants, 50 times/min for older children>); (4) dyspnea (three concave sign, moaning, nasal flapping) (5) hypoxemia (cyanosis, transcutaneous oxygen saturation< 92% (not oxygenated)); (6) Pulmonary infiltration≥ 2/3 lung or multilobar infiltration; (7) There is a pleural effusion; (8) Extrapulmonary complications Exclusion Criteria: Systemic corticosteroids have been used to treat pneumonia before admission. Use systemic glucocorticoids within 3 months before admission. Hospital-acquired pneumonia. Children with history of tuberculosis, branch expansion, tumors, immune deficiency, congenital heart, chronic pulmonary heart disease, kidney disease, severe malnutrition, recurrent respiratory infections, congenital bronchopulmonary dysplasia (BPD) and other underlying diseases. Unconscious, need endotracheal intubation, children admitted to ICU. Those who are allergic to the drugs or their preparation components involved in the study. Those with hormonal contraindications: hypertension, diabetes, active peptic ulcer, adrenal hyperfunction, corneal ulcer, increased intraocular pressure, severe psychosis. There is a current infection that is difficult to control with antibacterial drugs. Children who are participating in other clinical trials. The investigator believes that it is not suitable to participate in the study.
Sites / Locations
- Baoding Children's HospitalRecruiting
- Beijing Children's HospitalRecruiting
- Beijing Fangshan District Health Care HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Experimental group
Placebo group
Prednisolone, oral, 2 mg/kg.d (maximum dose 60 mg/day), two or three times a day , 5 days.
The same amount of placebo was taken orally as the trial for 5 days